EUVIMEDEUVIMED entdecken
Crossref

The FDA’s New Clinical Decision Support Software Guidance and Its Implications for Artificial Intelligence

Utah Law Review · 2026 · 2026 (4)

DOI: 10.63140/z78d.cf0n3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Utah Law Review, 2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). The FDA’s New Clinical Decision Support Software Guidance and Its Implications for Artificial Intelligence. Utah Law Review, 2026(4). https://doi.org/10.63140/z78d.cf0n3

Vancouver

The FDA’s New Clinical Decision Support Software Guidance and Its Implications for Artificial Intelligence. Utah Law Review. 2026;2026(4). doi:10.63140/z78d.cf0n3

BibTeX
@article{euvimed2026,
  title = {The FDA’s New Clinical Decision Support Software Guidance and Its Implications for Artificial Intelligence},
  journal = {Utah Law Review},
  year = {2026},
  volume = {2026},
  number = {4},
  doi = {10.63140/z78d.cf0n3}
}
Kostenlos starten →